跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
法布赞 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Agalsidase Beta for Injection
Approved
生物制品
Agalsidase Beta for Injection
Sanofi B.V.
🇨🇳 National Medical Products Administration
Approval Date
Apr 25, 2024
Approval ID
8b3GrjVhwHt
Company
Sanofi B.V.
Type
生物制品
Approval Details
Approval Id
8b3GrjVhwHt
Approval Number
国药准字SJ20190041
Generic Name
注射用阿加糖酶β
Generic Name En
Agalsidase Beta for Injection
Trade Name
法布赞
Drug Type
生物制品
Dosage Form
注射剂
Strength
35mg/瓶
Reg Date
2024-04-25
Expired Date
2029-04-24
Company Name
Sanofi B.V.
Production Company Name
GENZYME IRELAND LIMITED
Company Detail Path
/organization/sanofi-b-v
Production Company Detail Path
/organization/genzyme-ireland-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 25, 2024
Approval ID
8b3GrjVhwHt
Type
生物制品
Back to NMPA Approvals